Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year.
about
Niemann-Pick disease type CDysphagia as a risk factor for mortality in Niemann-Pick disease type C: systematic literature review and evidence from studies with miglustatChemical screen to reduce sterol accumulation in Niemann-Pick C disease cells identifies novel lysosomal acid lipase inhibitors.Corneal alterations during combined therapy with cyclodextrin/allopregnanolone and miglustat in a knock-out mouse model of NPC1 disease.Development of targeted therapies for Parkinson's disease and related synucleinopathiesTreatment of a child diagnosed with Niemann-Pick disease type C with miglustat: a case report in Brazil.Miglustat improves purkinje cell survival and alters microglial phenotype in feline Niemann-Pick disease type C.Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C.Therapeutic approaches to the challenge of neuronal ceroid lipofuscinoses.Substrate reduction therapy.Differential sensitivity of mouse strains to an N-alkylated imino sugar: glycosphingolipid metabolism and acrosome formationNew therapies in the management of Niemann-Pick type C disease: clinical utility of miglustatLong-term miglustat therapy in children with Niemann-Pick disease type C.Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C.Delivering drugs to the central nervous system: an overview.Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.Miglustat in Niemann-Pick disease type C patients: a review
P2860
Q21202883-2BAF1870-8B51-46CD-A7C6-100046CEA7DDQ26825102-0D523B54-92C7-45B4-9404-A7172DCEB405Q30872586-21564E6D-3085-4BCF-826F-C67701C22BC0Q34097846-3142181F-65B1-4205-9E04-873E9E3BAF66Q34238616-BD5D2520-DB5E-4031-B179-0410671E2B56Q34860824-EC0FDF8B-BC44-413D-B536-B86ADDE1D5E7Q35960437-EBAF5D27-C7D3-42F3-9244-1ABF275B61B3Q36299871-53DC7333-3391-4B35-AAE5-499C690E77DCQ36784566-59B638AB-9302-44FA-B7C6-DEB895B1F7F5Q37109614-7E1A7E4F-BCBC-442C-8A1E-D2F31BCB32E6Q37179532-CB315E3E-9DAE-4CEF-B0FF-B5A8BE20CB2AQ37429819-E86043E4-8551-496A-BF73-BF20B6282222Q43263006-B71B7145-7F00-4205-A7E0-B6A31796E89DQ43607199-2EB56DBF-F689-4A8E-89C6-A3A97BDEC8B9Q48489684-4B0FF418-A0FE-4F70-AD74-9EDDA60C9D55Q50358080-C84D32D8-36E1-4F5B-BAA1-F2434CB94369Q58778074-5B49814C-2E63-4DD8-80CB-4851CD7C3B9F
P2860
Treatment of Niemann-Pick disease type C in two children with miglustat: initial responses and maintenance of effects over 1 year.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
Treatment of Niemann-Pick dise ...... enance of effects over 1 year.
@en
Treatment of Niemann-Pick dise ...... enance of effects over 1 year.
@nl
type
label
Treatment of Niemann-Pick dise ...... enance of effects over 1 year.
@en
Treatment of Niemann-Pick dise ...... enance of effects over 1 year.
@nl
prefLabel
Treatment of Niemann-Pick dise ...... enance of effects over 1 year.
@en
Treatment of Niemann-Pick dise ...... enance of effects over 1 year.
@nl
P50
P1476
Treatment of Niemann-Pick dise ...... tenance of effects over 1 year
@en
P2093
P2888
P356
10.1007/S10545-007-0630-Y
P577
2007-06-21T00:00:00Z